Show simple item record

dc.contributor.authorKas, Martien J
dc.contributor.authorKahn, René S
dc.contributor.authorCollier, David A
dc.contributor.authorWaddington, John L
dc.contributor.authorEkelund, Jesper
dc.contributor.authorPorteous, David J
dc.contributor.authorSchughart, Klaus
dc.contributor.authorHovatta, Iiris
dc.date.accessioned2012-03-13T08:57:16Zen
dc.date.available2012-03-13T08:57:16Zen
dc.date.issued2011-09-28en
dc.identifier.citationTranslational neuroscience of Schizophrenia: seeking a meeting of minds between mouse and man. 2011, 3 (102):102mr3 Sci Transl Meden_GB
dc.identifier.issn1946-6242en
dc.identifier.pmid21957171en
dc.identifier.doi10.1126/scitranslmed.3002917en
dc.identifier.urihttp://hdl.handle.net/10033/215470en
dc.description.abstractUnderstanding the etiology of developmental brain disorders such as schizophrenia is critical for achieving advances in treatment and requires new research strategies that control for individual variation in genetic background, environmental challenges, and expression of phenotype. SYSGENET, a European systems genetics network for the study of complex genetic human diseases with mouse genetic reference populations, brought together in Helsinki a cross-disciplinary group of clinical and basic scientists and mouse geneticists to debate, formulate, and prioritize a strategy for future research based on mouse models. The main conclusions of this meeting are summarized here.
dc.language.isoenen
dc.rightsArchived with thanks to Science translational medicineen_GB
dc.titleTranslational neuroscience of Schizophrenia: seeking a meeting of minds between mouse and man.en
dc.typeArticleen
dc.contributor.departmentDepartment of Neuroscience and Pharmacology, University Medical Center Utrecht, 3584CG Utrecht, The Netherlands. m.j.h.kas@umcutrecht.nlen_GB
dc.identifier.journalScience translational medicineen_GB
refterms.dateFOA2018-06-13T00:26:11Z
html.description.abstractUnderstanding the etiology of developmental brain disorders such as schizophrenia is critical for achieving advances in treatment and requires new research strategies that control for individual variation in genetic background, environmental challenges, and expression of phenotype. SYSGENET, a European systems genetics network for the study of complex genetic human diseases with mouse genetic reference populations, brought together in Helsinki a cross-disciplinary group of clinical and basic scientists and mouse geneticists to debate, formulate, and prioritize a strategy for future research based on mouse models. The main conclusions of this meeting are summarized here.


Files in this item

Thumbnail
Name:
Kas et al_final.pdf
Size:
199.7Kb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record